Back to JPMORGAN CHASE & CO JPMORGAN CHASE & CO

NAMSNAMS
7 quarters

Position history for JPMORGAN CHASE & COJPMORGAN CHASE & CO's holdings in NewAmsterdam Pharma Company N.V.

JPMORGAN CHASE & CO holds 1.1M shares of NAMS (NewAmsterdam Pharma Company N.V.), worth $38.4M as of 2026-Q2. The position was increased (+28.1% shares). NAMS represents 0.0% of JPMORGAN CHASE & CO's portfolio.

Current Value

$38.4M

Current Shares

1.1M

Total Value Change

+$36.8M

Total Shares Change

+1.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.1M
+28.1%
$38.4M0.0%$33.89
36
2026-Q1
Decreased
884,228
-11.6%
$25.9M0.0%$30.41
0
2025-Q4
Decreased
999,976
-61.6%
$35.1M0.0%$34.74
0
2025-Q3
Increased
2.6M
+78.6%
$74.1M0.0%$27.52
45
2025-Q2
Increased
1.5M
+47.2%
$26.4M0.0%$18.57
39
2025-Q1
Increased
991,318
+1525.7%
$20.3M0.0%$21.76
46
2024-Q4
New
60,977
-
$1.6M0.0%$25.60
35

Other major holders of NAMS: Capital World Investors, FMR LLC, RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used